Skip to main content

Advertisement

SpringerLink
Log in

Lasers for lower urinary tract symptoms secondary to benign prostatic hyperplasia: When is the fuss worth it?

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

In the recent past, several endoscopic procedures using laser technology have evolved for the treatment of benign prostatic hyperplasia. The term “laser treatment of the prostate” comprises a variety of different application systems, different laser wavelengths, and different surgical techniques to eliminate bladder outlet obstruction. The aim of laser prostatectomy is to be less invasive than transurethral electroresection, but equally effective. Promising short-term results led to a booming laser decade in the 1990s, stimulating the development of several devices. However, the emergence of medium-term data has shown that some of these techniques did not stand the test of time due to the lack of long-term efficacy, unacceptable morbidity, and high retreatment rates. Nevertheless, the results of transurethral resection of the prostate are challenged by some of the newer laser devices, putting the socalled “gold standard” into question.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Roehrborn CG, Issa MM, Bruskewitz RC, et al.: Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology 1998, 51:415–421.

    Article  PubMed  CAS  Google Scholar 

  2. Wheelahan J, Scott NA, Cartmill R, et al.: Minimally invasive laser techniques for prostatectomy: a systematic review. The ASERNIP-S review group. Australian Safety and Efficacy Register of New Interventional Procedures: Surgical. BJU Int 2000, 86:805–815.

    Article  PubMed  CAS  Google Scholar 

  3. Dixon CM: Lasers for the treatment of benign prostatic hyperplasia. Urol Clin North Am 1995, 22:413–422.

    PubMed  CAS  Google Scholar 

  4. te Slaa E, de la Rosette JJ: Lasers in the treatment of benign prostatic obstruction: past, present, and future. Eur Urol 1996, 30:1–10.

    Google Scholar 

  5. Wasson JH, Reda DJ, Bruskewitz RC, et al.: A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995, 332:75–79.

    Article  PubMed  CAS  Google Scholar 

  6. Horninger W, Unterlechner H, Strasser H, et al.: Transurethral prostatectomy: mortality and morbidity. Prostate 1996, 28:195–200.

    Article  PubMed  CAS  Google Scholar 

  7. Oesterling JE: Benign prostatic hyperplasia: medical and minimally invasive treatment options. N Engl J Med 1995, 332:99–109.

    Article  PubMed  CAS  Google Scholar 

  8. Ansari MZ, Costello AJ, Jolley DJ, et al.: Adverse events after prostatectomy in Victorian public hospitals. Aust N Z J Surg 1998, 68:830–836.

    Article  PubMed  CAS  Google Scholar 

  9. Beisland HO, Sander S: First clinical experiences on neodymium YAG laser irradiation of localized prostatic cancer. Scand J Urol Nephrol 1986, 20:113–117.

    PubMed  CAS  Google Scholar 

  10. Johnson DE, Price RE, Cromeens DM: Pathologic changes occurring in the prostate following transurethral laser prostatectomy. Lasers Surg Med 1992, 12:254–263.

    Article  PubMed  CAS  Google Scholar 

  11. Kandel LB, Harrison LH, McCullough DL, et al.: Transurethral laser prostatectomy in the canine model. Lasers Surg Med 1992, 12:33–42.

    Article  PubMed  CAS  Google Scholar 

  12. Costello AJ, Bowsher WG, Bolton DM, et al.: Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 1992, 69:603–608. This paper is the first report of clinical laser prostatectomy. The years that followed were characterized by a worldwide enthusiasm for lasers in the treatment of BPH, particularly for the Nd:YAG device.

    PubMed  CAS  Google Scholar 

  13. Narayan P, Tewari A, Aboseif S, et al.: A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia. J Urol 1995, 154:2083–2088.

    Article  PubMed  CAS  Google Scholar 

  14. Muschter R, Perlmutter AP: The optimization of laser prostatectomy. Part II: other lasing techniques. Urology 1994, 44:856–861.

    Article  PubMed  CAS  Google Scholar 

  15. Cowles RS III, Kabalin JN, Childs S, et al.: A prospective, randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995, 46:155–160.

    Article  PubMed  Google Scholar 

  16. Gerber GS: Lasers in the treatment of benign prostatic hyperplasia. Urology 1995, 45:193–199.

    Article  PubMed  CAS  Google Scholar 

  17. Narayan P, Tewari A, Schalow E, et al.: Transurethral evaporation of the prostate for treatment of benign prostatic hyperplasia: results in 168 patients with up to 12 months of follow-up. J Urol 1997, 157:1309–1312.

    Article  PubMed  CAS  Google Scholar 

  18. Schatzl G, Madersbacher S, Lang T, et al.: The early postoperative morbidity of transurethral resection of the prostate and of four minimally invasive treatment alternatives. J Urol 1997, 158:105–110.

    Article  PubMed  CAS  Google Scholar 

  19. Costello AJ, Kabalin JN: Side-firing Neodymium:YAG laser prostatectomy. Eur Urol 1999, 35:138–146.

    Article  PubMed  CAS  Google Scholar 

  20. Anson K, Nawrocki J, Buckley J, et al.: A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995, 46:305–310.

    Article  PubMed  CAS  Google Scholar 

  21. Kabalin JN, Gill HS, Bite G, et al.: Comparative study of laser versus electrocautery prostatic resection: 18-month followup with complex urodynamic assessment. J Urol 1995, 153:94–98.

    Article  PubMed  CAS  Google Scholar 

  22. Sengor F, Kose O, Yucebas E, et al.: A comparative study of laser ablation and transurethral electroresection for benign prostatic hyperplasia: results of a 6-month follow-up. Br J Urol 1996, 78:398–400.

    PubMed  CAS  Google Scholar 

  23. Keoghane SR, Sullivan ME, Doll HA, et al.: Five-year data from the Oxford Laser Prostatectomy Trial. BJU Int 2000, 86:227–228.

    Article  PubMed  CAS  Google Scholar 

  24. Gujral S, Abrams P, Donovan JL, et al.: A prospective, randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: the CLasP study. J Urol 2000, 164:59–64.

    Article  PubMed  CAS  Google Scholar 

  25. Shingleton WB, Farabaugh P, May W: Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002, 60:305–308.

    Article  PubMed  Google Scholar 

  26. Planz B, Kalem T, Sprenger C, et al.: A prospective, randomized study of combined visual laser ablation and transurethral resection of the prostate versus transurethral prostatectomy alone. Urol Int 2003, 71:26–30.

    Article  PubMed  Google Scholar 

  27. Perachino M, Puppo P: Prostatectomia laser con metodica sidefire: risultati a distanza di 5 anni. Acta Urol Ital 1998, 12:44. Disappointing 5-year results with unacceptable high retreatment rates.

    Google Scholar 

  28. Muschter R, Hofstetter A: Technique and results of interstitial laser coagulation. World J Urol 1995, 13:109–114.

    Article  PubMed  CAS  Google Scholar 

  29. Kursh ED, Concepcion R, Chan S, et al.: Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up. Urology 2003, 61:573–578.

    Article  PubMed  Google Scholar 

  30. Muschter R, Whitfield H: Interstitial laser therapy of benign prostatic hyperplasia. Eur Urol 1999, 35:147–154.

    Article  PubMed  CAS  Google Scholar 

  31. Norby B, Nielsen HV, Frimodt-Moller PC: Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 2002, 90:853–862.

    Article  PubMed  CAS  Google Scholar 

  32. Malek RS, Barrett DM, Kuntzman RS: High-power potassiumtitanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998, 51:254–256.

    Article  PubMed  CAS  Google Scholar 

  33. Kuntzman RS, Malek RS, Barrett DM: High-power potassium titanyl phosphate laser vaporization prostatectomy. Mayo Clin Proc 1998, 73:798–801.

    PubMed  CAS  Google Scholar 

  34. Kumar SM: Photoselective vaporization of the prostate: a volume-reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol 2005, 173:511–513.

    Article  PubMed  Google Scholar 

  35. Te AE, Malloy TR, Stein BS, et al.: Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter, prospective trial. J Urol 2004, 172:1404–1408.

    Article  PubMed  Google Scholar 

  36. Reich O, Bachmann A, Siebels M, et al.: High-power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005, 173:158–160. This most recent report focuses on the efficacy and safety profile of this relatively new technique.

    Article  PubMed  Google Scholar 

  37. Gilling PJ, Cass CB, Cresswell MD, et al.: Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 1996, 47:48–51. This landmark study assessed the early efficacy and safety of holmium laser resection of the prostate in patients with symptomatic BPH.

    Article  PubMed  CAS  Google Scholar 

  38. Gilling PJ, Cass CB, Cresswell MD, et al.: The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol 1996, 10:459–461.

    PubMed  CAS  Google Scholar 

  39. Gilling PJ, Kennett K, Das AK, et al.: Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol 1998, 12:457–459.

    PubMed  CAS  Google Scholar 

  40. Hochreiter W, Hugonnet C, Studer UE: [Transurethral resection of the prostate with the Holmium contact laser: Progress in treatment of benign prostatic hypertrophy?]. Urologe A 1999, 38:156–161.

    Article  PubMed  CAS  Google Scholar 

  41. Bukala B, Denstedt JD: Holmium:YAG laser resection of the prostate. J Endourol 1999, 13:215–219.

    PubMed  CAS  Google Scholar 

  42. Matsuoka K, Iida S, Tomiyasu K, et al.: Transurethral holmium laser resection of the prostate. J Urol 2000, 163:515–518.

    Article  PubMed  CAS  Google Scholar 

  43. Moody JA, Lingeman JE: Holmium laser enucleation of the prostate with tissue morcellation: initial United States experience. J Endourol 2000, 14:219–223.

    Article  PubMed  CAS  Google Scholar 

  44. Kuntz RM, Fayad A, Lehrich K, et al.: Transurethral holmium laser enucleation of the prostate (HoLEP): a prospective study on 100 patients with one year follow-up. Med Laser Appl 2001, 16:15–22. Noteworthy paper with emphasis on the technical performance.

    Article  Google Scholar 

  45. Le Duc A, Gilling PJ: Holmium laser resection of the prostate. Eur Urol 1999, 35:155–160.

    Article  PubMed  Google Scholar 

  46. Hochreiter WW, Thalmann GN, Burkhard FC, et al.: Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 2002, 168:1470–1474. This report describes an easy-to-do combination of holmium laser enucleation and electrocautery resection to retrieve the resected tissue without compromizing the hemostatic properties of the laser procedure.

    Article  PubMed  Google Scholar 

  47. Larizgoitia I, Pons JM: A systematic review of the clinical efficacy and effectiveness of the holmium:YAG laser in urology. BJU Int 1999, 84:1–9.

    Article  PubMed  CAS  Google Scholar 

  48. Fraundorfer MR, Gilling PJ, Kennett KM, et al.: Holmium laser resection of the prostate is more cost effective than transurethral resection of the prostate: results of a randomized prospective study. Urology 2001, 57:454–458.

    Article  PubMed  CAS  Google Scholar 

  49. Tan AH, Gilling PJ: Holmium laser prostatectomy. BJU Int 2003, 92:527–530.

    Article  PubMed  CAS  Google Scholar 

  50. Tooher R, Sutherland P, Costello A, et al.: A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol 2004, 171:1773–1781.

    Article  PubMed  Google Scholar 

  51. Gilling PJ, Kennett KM, Fraundorfer MR: Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up. J Endourol 2000, 14:757–760.

    PubMed  CAS  Google Scholar 

  52. Gilling PJ, Mackey M, Cresswell M, et al.: Holmium laser versus transurethral resection of the prostate: a randomized, prospective trial with 1-year follow-up. J Urol 1999, 162:1640–1644.

    Article  PubMed  CAS  Google Scholar 

  53. Kuntz RM, Lehrich K: Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.: a randomized, prospective trial of 120 patients. J Urol 2002, 168:1465–1469.

    Article  PubMed  Google Scholar 

  54. Aho TF, Gilling PJ: Laser therapy for benign prostatic hyperplasia: a review of recent developments. Curr Opin Urol 2003, 13:39–44.

    Article  PubMed  Google Scholar 

  55. Madersbacher S, Alivizatos G, Nordling J, et al.: EAU 2004 guidelines on assessment, therapy, and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004, 46:547–554.

    Article  PubMed  Google Scholar 

  56. AUA Practice Guidelines Committee: AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003, 170:530–547.

    Article  Google Scholar 

  57. de la Rosette JJ, Alivizatos G, Madersbacher S, et al.: EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2001, 40:256–264.

    Article  PubMed  Google Scholar 

  58. May F, Hartung R: Surgical treatment of BPH: technique and results. EAU Update Series 2004, 2:15–23.

    Article  Google Scholar 

  59. de la Rosette JJ, Gravas S, Muschter R, et al.: Present practice and development of minimally invasive techniques, imaging, and training in European urology: results of a survey of the European Society of Uro-Technology (ESUT). Eur Urol 2003, 44:346–351.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hirslanden Clinic Aarau, Urology Center, CH-5001, Schaenisweg, Aarau, Switzerland

    Werner W. Hochreiter MD

Authors
  1. Werner W. Hochreiter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger M. Müller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hochreiter, W.W., Müller, R.M. Lasers for lower urinary tract symptoms secondary to benign prostatic hyperplasia: When is the fuss worth it?. Curr Urol Rep 6, 257–262 (2005). https://doi.org/10.1007/s11934-005-0018-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-005-0018-1

Keywords

Search

Navigation